|
PF-33813 |
ALBUREX 25 % Solución para infusión |
2029-11-11 |
|
CSL Behring AG |
Suiza
|
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-46727 |
PRIVIGEN 10 % Solución para infusión. |
2026-11-05 |
|
CSL Behring AG |
Suiza
|
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38550 |
TETANOGAMMA P 250 UI/mL Solución inyectable |
2026-11-30 |
|
CSL Behring GmbH |
Alemania
|
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-49731 |
BERIATE 250 UI/2.5 mL, 500 UI/5 mL, 1000 UI/10 mL Polvo y Disolvente Para Solución Inyectable o Para Perfusión |
2029-02-05 |
|
CSL Behring GmbH |
Alemania
|
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-10010 |
STREPTASE 1,500,000 UI Liofilizado para uso parenteral |
2015-08-20 |
|
CSL Behring GmbH |
Alemania
|
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-32477 |
FACTOR VIII CSL Limited 50 UI/mL Polvo y solución para Uso Parenteral |
2019-04-21 |
|
CSL Limited |
Australia
|
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-32067 |
PIROXICAM Caplin Point Laboratories LTD. 20 mg Cápsulas |
2019-02-03 |
|
Caplin Point Laboratories Ltd. |
India
|
Neoethicals |
Servi-Logistics |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55091 |
LipAd 2 mg / mL Suspensión Liposomada Pegilada Inyectable |
2023-03-22 |
|
Caplin Point Laboratories Limited |
República de China
|
Neoethicals |
Servi-Logistics |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55229 |
ACIDO ACETILSALICILICO CAPLIN 100 mg Tabletas |
2023-05-04 |
|
Caplin Point Laboratories Limited |
República de China
|
Neoethicals |
Servi-Logistics |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-57378 |
CAPTOPRIL Caplin 50 mg Tabletas |
2024-10-28 |
|
Caplin Point Laboratories Limited |
República de China
|
Neoethicals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|